EMEA-001526-PIP01-13-M05

Key facts

Invented name
Natpar
Active substance
Recombinant parathyroid hormone
Therapeutic area
Endocrinology-Gynaecology-Fertility-Metabolism
Decision number
P/0369/2021
PIP number
EMEA-001526-PIP01-13-M05
Pharmaceutical form(s)
Powder and solvent for solution for injection
Condition(s) / indication(s)
Treatment of hypoparathyroidism
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Takeda Pharmaceuticals International AG Ireland Branch

E-mail: medinfoEMEA@takeda.com
Tel: +41 79 758 4815

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating
Average
1 rating